Skip to main content

ReGen group joins Barts Bone & Joint Health

This week, the ReGen group led by Professor Francesco Dell’Accio joins Barts Bone & Joint Health, and have moved their labs to the Centre for Neuroscience, Surgery and Trauma in the Blizard Institute. They remain part of the William Harvey Research Institute, and will continue their work on developing pharmacological interventions to restore cartilage integrity and to reduce pain in osteoarthritis and other cartilage defects.

Professor Francesco Dell’Accio and Dr Suzanne E. Eldridge

Professor Francesco Dell’Accio and Dr Suzanne E. Eldridge

Professor Francesco Dell’Accio (Professor of Musculoskeletal Regenerative Medicine and Rheumatology) and Dr Suzanne Eldridge (Senior Lecturer in Musculoskeletal Regenerative Medicine) comment on their move: "We are very excited to have joined Professor Xavier Griffin and his Bone & Joint Health team, based in the Centre for Neuroscience, Surgery and Trauma, at the Blizard Institute! Our ReGen group investigates the mechanisms of healing of the joint surface and the pathogenesis of osteoarthritis. As well as pursuing basic scientific discoveries we are committed to commercialising three novel molecules that we have developed which support cartilage regeneration, and to produce the first disease modifying drug for osteoarthritis. 

"The team, co-led by Professor Francesco Dell’Accio and Dr Suzanne E. Eldridge, is made up of post-docs, PhD students and technicians. Our expertise spans all aspects of musculoskeletal regeneration, mechanisms of pain, drug production and animal models. We look forward to meeting everyone and collaborating in the future!

"We'd like to say a big thank you to everyone who's supported this move, helped us, and gave us a really warm welcome."

Professor Xavier Griffin, Chair of Barts Bone & Joint Health, said: "We are delighted to welcome the ReGen group to Barts Bone & Joint Health. The pioneering work led by Professor Dell'Accio has incredible potential to transform the lives of those with osteoarthritis. The coming together of our groups will provide fantastic training opportunities for the next generation of clinical academics and our home in the Blizard Institute positions us to realise our ambition in becoming world leaders in bone and joint disorders and injuries."

Pease join us in welcoming Professor Dell’Accio's and Dr Eldridge's labs to the Blizard Institute.



Back to top